Our goal at the University at Buffalo (UB) is to increase the number of PhD students from underrepresented groups in biomedical and behavioral science. The IMSD at UB has had an essential role in this strategy by recruiting, providing access to first-class research, and supporting students through collaborative learning and integrated mentoring.
The specific aims for the next budget period are: 1) To increase the number of underrepresented PhD students in biomedical and behavioral disciplines at UB by four per year amounting to a total increase of 20 during the 5-year funding period. This will be accomplished by targeted recruiting and holistic review to admit talented and motivated students from underrepresented groups that enhance educational outcomes. 2) To provide integrated mentoring and essential academic support for successful completion of the PhD degree and to secure competitive fellowships and awards. The program will guide students through their PhD training using an IDP to tailor their research interests, professional development activities, and integrated mentoring support through their student advisory group. 3) To prepare students to successfully transition into competitive postdoctoral positions by facilitating access to careers in science and leadership positions, lectures and workshops and opportunities to interact with academic, federal, and industry leaders. To grow professional networks and foster mentor relationships, IMSD students will complete a research and/or professional development internships and explore potential future career paths. 4) Finally, to provide a rich, intellectually diverse and inclusive learning and research environment.
This aim will be accomplished through integrating the student to faculty development programs at UB and SUNY wide with the IMSD programming. Collaborative partnerships with the office of the UB Vice-provost for Equity and Inclusion, the Office of Inclusion and Cultural Enhancement, and UB senior administration will be formed to develop specific activities including workshops catered to UB graduate program directors and admissions committees, administrators and faculty search committees. The success of the IMSD program will be measured by: a) increasing diversity of students and faculty applicant pools, b) students' scientific productivity and entry into the workforce, c) improved faculty mentoring and support, and d) building a more inclusive climate at UB.

Public Health Relevance

The goal of the initiative for Maximizing Student Development (IMSD) program at UB is to facilitate successful completion of PhD degrees in biomedical and behavioral science of underrepresented students (e.g., AA: African Americans, HA: Hispanic Americans, NA: Native Americans; PI: Pacific/Hawaiian Islanders, economically disadvantaged, and individuals with disabilities). We believe that by providing professional development and mentoring, students will produce outstanding research, excel in their graduate training and successfully enter the scientific workforce. A diverse workforce will initiate health science research and collaborations to discover treatments and impact policy that affect traditionally underrepresented populations bridging the gap in health disparities.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Education Projects (R25)
Project #
3R25GM095459-09S1
Application #
10156458
Study Section
Program Officer
Koduri, Sailaja
Project Start
2012-03-28
Project End
2021-12-31
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
9
Fiscal Year
2020
Total Cost
Indirect Cost
Name
State University of New York at Buffalo
Department
Pharmacology
Type
Schools of Medicine
DUNS #
038633251
City
Amherst
State
NY
Country
United States
Zip Code
14228
Choi, Jin-Ok; Fan, Chuandong; Kim, Dongkyeong et al. (2018) Elucidating the transactivation domain of the pleiotropic transcription factor Myrf. Sci Rep 8:13075
Martin, Jennifer A; Caccamise, Aaron; Werner, Craig T et al. (2018) A Novel Role for Oligodendrocyte Precursor Cells (OPCs) and Sox10 in Mediating Cellular and Behavioral Responses to Heroin. Neuropsychopharmacology 43:1385-1394
Welliver, R Ross; Polanco, Jessie J; Seidman, Richard A et al. (2018) Muscarinic receptor M3R signaling prevents efficient remyelination by human and mouse oligodendrocyte progenitor cells. J Neurosci :
Cheli, Veronica T; Santiago González, Diara A; Marziali, Leandro N et al. (2018) The Divalent Metal Transporter 1 (DMT1) Is Required for Iron Uptake and Normal Development of Oligodendrocyte Progenitor Cells. J Neurosci 38:9142-9159
Cheli, Veronica T; Santiago González, Diara A; Zamora, Norma N et al. (2018) Enhanced oligodendrocyte maturation and myelination in a mouse model of Timothy syndrome. Glia 66:2324-2339
Eichmiller, Robin; Medina-Rivera, Melisa; DeSanto, Rachel et al. (2018) Coordination of Rad1-Rad10 interactions with Msh2-Msh3, Saw1 and RPA is essential for functional 3' non-homologous tail removal. Nucleic Acids Res 46:5075-5096
Seol, Ja-Hwan; Holland, Cory; Li, Xiaolei et al. (2018) Distinct roles of XPF-ERCC1 and Rad1-Rad10-Saw1 in replication-coupled and uncoupled inter-strand crosslink repair. Nat Commun 9:2025
Long, Mark D; Singh, Prashant K; Russell, James R et al. (2018) The miR-96 and RAR? signaling axis governs androgen signaling and prostate cancer progression. Oncogene :
Bianchi-Smiraglia, Anna; Bagati, Archis; Fink, Emily E et al. (2018) Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma. J Clin Invest 128:4682-4696
Song, Eun-Ah Christine; Min, Sangwon; Oyelakin, Akinsola et al. (2018) Genetic and scRNA-seq Analysis Reveals Distinct Cell Populations that Contribute to Salivary Gland Development and Maintenance. Sci Rep 8:14043

Showing the most recent 10 out of 35 publications